CINCINNATI--(BUSINESS WIRE)--Jan. 18, 2012--
Bioline, The PCR Company, a wholly-owned subsidiary of Meridian
Bioscience, Inc. (NASDAQ:VIVO), is proud to announce the latest addition
to its HyperPAGE range of prestained molecular weight protein markers.
HyperPAGE II contains 9 highly purified protein bands from 10 to 250kDa
prestained with different fluorescence dyes to facilitate easy
identification and orientation whether performing protein
electrophoresis by SDS-PAGE or Western Blotting.
The protein marker is ideal to monitor efficiency in electrophoresis and
transfer of proteins from gel to membrane following Western blotting,
and to estimate the molecular weight of protein samples.
Marco Calzavara, President at Bioline, commented, “The new HyperPAGE II
prestained protein marker facilitates protein electrophoresis by
offering sharp, accurate and easily identifiable bright bands as is
already familiar to existing HyperPAGE customers but now also in an
easier, ready-to-use format.”
Richard L. Eberly, Chief Commercial Officer of Meridian Bioscience,
Inc., stated, “HyperPAGE II maintains the quality and accuracy that
researchers have come to expect from Bioline and demonstrates our
commitment to help life science customers in the research lab, clinical
diagnostic labs, diagnostic manufacturers, and biotech companies.”
ABOUT MERIDIAN BIOSCIENCE, INC.
Meridian is a fully integrated life science company that manufactures,
markets and distributes a broad range of innovative diagnostic test
kits, purified reagents and related products and offers
biopharmaceutical enabling technologies. Utilizing a variety of methods,
these products and diagnostic tests provide accuracy, simplicity and
speed in the early diagnosis and treatment of common medical conditions,
such as gastrointestinal, viral and respiratory infections. Meridian’s
diagnostic products are used outside of the human body and require
little or no special equipment. The Company's products are designed to
enhance patient well-being while reducing the total outcome costs of
healthcare. Meridian has strong market positions in the areas of
gastrointestinal and upper respiratory infections, serology,
parasitology and fungal disease diagnosis. In addition, Meridian is a
supplier of rare reagents, specialty biologicals and related
technologies used by biopharmaceutical companies engaged in research for
new drugs and vaccines. The Company markets its products and
technologies to hospitals, reference laboratories, research centers,
veterinary testing centers, diagnostics manufacturers and biotech
companies in more than 60 countries around the world. The Company’s
shares are traded through NASDAQ’s Global Select Market, symbol VIVO.
Meridian's website address is www.meridianbioscience.com.
For more information about Bioline, please visit www.bioline.com.
more information about Meridian Life Science, Inc., please visit www.meridianlifescience.com.
more information about Meridian Bioscience, Inc., please visit www.meridianbioscience.com.
Source: Meridian Bioscience, Inc.
Meridian Bioscience, Inc.
Richard L. Eberly, Chief Commercial